| |
Latest 10 SEC filings (by transaction date) for CTMX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 26/24 | McCarthy Sean A. | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -109,768 | |
Mar 28/24 | Mar 26/24 | McCarthy Sean A. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 109,768 | $1.57 |
Mar 22/24 | Mar 20/24 | Su Zhen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 76,000 | |
Mar 21/24 | Mar 19/24 | Rowland Lloyd A | Direct Ownership | Common Stock | S - Open market or private sale | -5,268 | $2.09 |
Mar 21/24 | Mar 19/24 | McCarthy Sean A. | Direct Ownership | Common Stock | S - Open market or private sale | -20,223 | $2.09 |
Mar 21/24 | Mar 19/24 | Ogden Christopher | Direct Ownership | Common Stock | S - Open market or private sale | -2,971 | $2.09 |
Mar 21/24 | Mar 19/24 | Belvin Marcia | Direct Ownership | Common Stock | S - Open market or private sale | -12,795 | $2.09 |
Mar 21/24 | Mar 19/24 | Landau Jeffrey B | Direct Ownership | Common Stock | S - Open market or private sale | -6,562 | $2.09 |
Jan 19/24 | Jan 18/24 | McCarthy Sean A. | Direct Ownership | Performance Stock Units (PSUs) | A - Grant, award or other under Rule 16b-3(d) | 260,000 | |
Jan 19/24 | Jan 18/24 | McCarthy Sean A. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 420,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CTMX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 26/24 | McCarthy Sean A. | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -109,768 | |
Mar 28/24 | Mar 26/24 | McCarthy Sean A. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 109,768 | $1.57 |
Mar 22/24 | Mar 20/24 | Su Zhen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 76,000 | |
Mar 21/24 | Mar 19/24 | Rowland Lloyd A | Direct Ownership | Common Stock | S - Open market or private sale | -5,268 | $2.09 |
Mar 21/24 | Mar 19/24 | McCarthy Sean A. | Direct Ownership | Common Stock | S - Open market or private sale | -20,223 | $2.09 |
Mar 21/24 | Mar 19/24 | Ogden Christopher | Direct Ownership | Common Stock | S - Open market or private sale | -2,971 | $2.09 |
Mar 21/24 | Mar 19/24 | Belvin Marcia | Direct Ownership | Common Stock | S - Open market or private sale | -12,795 | $2.09 |
Mar 21/24 | Mar 19/24 | Landau Jeffrey B | Direct Ownership | Common Stock | S - Open market or private sale | -6,562 | $2.09 |
Jan 19/24 | Jan 18/24 | McCarthy Sean A. | Direct Ownership | Performance Stock Units (PSUs) | A - Grant, award or other under Rule 16b-3(d) | 260,000 | |
Jan 19/24 | Jan 18/24 | McCarthy Sean A. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 420,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |